The potential market is huge, but the regulatory hurdles for protein drugs is incredibly high--especially when the Food and Drug Administration is likely to become more gun shy when it comes to drug safety.
This finding is in line with modern thinking that a lot of evolutionary change is connected with regulatory elements rather than actual protein structure.